Item 1(a). |
Name of Issuer:
|
Oncorus, Inc. (the “Issuer”)
Item 1(b). |
Address of Issuer’s Principal Executive
Offices:
|
50 Hampshire Street, Suite 401, Cambridge, Massachusetts 02139
Item 2(a). |
Names of Persons Filing:
|
The names of the persons filing this report (collectively, the
“Reporting Persons”) are:
Perceptive Advisors LLC (“Perceptive Advisors”)
Joseph Edelman (“Mr. Edelman”)
Perceptive Life Sciences Master Fund, Ltd. (the “Master Fund”)
Item 2(b). |
Address of Principal Business Office or, if
None, Residence:
|
The address of the principal business office of each of the
Reporting Persons is:
51 Astor Place, 10th Floor
New York, NY 10003
Perceptive Advisors is a Delaware limited liability company
Mr. Edelman is a United States citizen
The Master Fund is a Cayman Islands corporation
Item 2(d). |
Title of Class of
Securities:
|
Common Stock, $0.0001 par value per share (“Common Stock”)
68236R 103
Item 3. |
If this statement is filed pursuant to
§§240.13d-1(b) or 240.13d-2(b) or (c), check
whether the person filing is a:
|
Not applicable.
The information required by this item with respect to each
Reporting Person is set forth in Rows 5 through 9 and 11 of the
cover page to this Schedule 13G. The ownership percentages reported
are based on 25,617,938 outstanding shares of Common Stock, as
reported in the Issuer’s prospectus supplement filed on
December 12, 2020.
The Master Fund directly holds 1,989,987 shares of Common Stock.
Perceptive Advisors serves as the investment manager to the Master
Fund and may be deemed to beneficially own such shares.
Mr. Edelman is the managing member of Perceptive Advisors and
may be deemed to beneficially own such shares.